Business Context and Reporting Period
This Form 6-K filing by Concord Medical Services Holdings Limited (NYSE: CCM) dated August 29, 2024, serves to disclose the interim results of its subsidiary, Concord Healthcare Group Co., Ltd. (Concord Healthcare), for the six months ended June 30, 2024. Concord Healthcare is listed on the Main Board of The Stock Exchange of Hong Kong Limited (HKSE) under stock code 2453.HK, following the listing of its H shares on January 9, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It acts as a cross-reference to the official announcement made on the HKSE website (www.hkexnews.hk) where the detailed financial data is published.
Material Changes
No material changes in financial performance or operational metrics are detailed within this specific filing text. The document solely references the availability of the interim results announcement.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a procedural filing to satisfy SEC reporting requirements regarding the subsidiary's public announcement.
Investor Verification Checklist
- Verify the specific interim financial results (revenue, net profit, EPS) by accessing the Concord Healthcare announcement on the HKSE website.
- Confirm the impact of the H-share listing on the subsidiary's capital structure and liquidity.
- Review the full text of the HKSE announcement for any segment-specific performance data or operational updates not included in this summary.